The FDA has given Qiagen approval for the QuantiFERON-TB Gold Plus test, the company's fourth-generation blood test designed for the detection of latent tuberculosis infection. The test, which is expected to be launched later this year, comes with a standard single-tube blood collection option that allows for processing of blood samples up to 53 hours following venipuncture without affecting the test accuracy.
Qiagen's 4th-gen tuberculosis blood test wins FDA nod
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.